Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas
Launched by ELIZABETH ARNOLD · May 11, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial aims to help prevent suicide among young adults aged 18 to 24 who identify as sexual and gender diverse. The study is testing two different short interventions designed to support these youth and reduce thoughts of suicide. Participants will be recruited from primary care clinics in Texas and will take part through telehealth, which means they can join the study from home. Each clinic will randomly be assigned to one of the two interventions to see which is more effective in helping these young adults.
To be eligible for this study, you must be between 18 and 24 years old, speak English, and have recently shown signs of thinking about suicide. Importantly, you should not have received mental health services in the past three months, except for medication. However, if you are currently feeling actively suicidal or have certain mental health conditions that would make it hard for you to participate, you will not be able to join. If you decide to take part, you will receive support and tools aimed at helping you cope with your feelings. This trial is currently recruiting participants, and your involvement could contribute to important findings that may help others in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • be aged 18-24 at the time of enrollment
- • not have received mental health services in the past 90 days, excluding medication and case management
- • English-speaking
- • screen positive for suicide risk
- Exclusion Criteria:
- • are actively suicidal
- • have a developmental disability that would preclude them from participating in the study intervention
- • who are impaired due to psychosis, mania, or substance use that would prevent them from providing consent.
- • Participants will also be excluded at YST-III sites if they are unable to identify a minimum of one support person to participate in the intervention with them
About Elizabeth Arnold
Elizabeth Arnold is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on fostering collaboration among stakeholders, including healthcare professionals, researchers, and regulatory bodies, Elizabeth Arnold ensures the highest standards of ethics and compliance in clinical trials. The organization emphasizes patient safety and data integrity while exploring groundbreaking therapies across various therapeutic areas, ultimately striving to contribute meaningful advancements to the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Austin, Texas, United States
Austin, Texas, United States
Patients applied
Trial Officials
Elizabeth Arnold, PhD
Principal Investigator
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported